Our Founder/CSO, Sareina Wu, will present our work as an invited speaker at Advanced Therapies Congress in Boston, USA. (November 4-5, 2026)
Speaker:
Sareina Wu, PhD
Chief Executive Officer (GenomeFrontier)
Time:
November 05, 2026 14:25 (GMT-4)
Cell Therapy Sponsored by Cellares Corporation (Track 1, Keynote Theatre)
Presentation topic:
Phase 1 experience with CD19/CD20 dual targeting
GF-CART01 for B cell lymphomas
More information: "Advanced Therapies Congress Official Website"